Nath Bio-genes (india) Ltd. · NSE:NATHBIOGEN
Nath Bio-genes (india) — Q1 FY27 Earnings Presentation
31 slides from Nath Bio-genes (india)'s earnings presentation, Jul 30, 2026
Slide 1: Cover letter to BSE and NSE on results presentation
30th July 2026 The Manager-Listing The Manager- Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code-537291 NSE Code-NATHBIOGEN Dear Sir/Madam, Subject- Presentation on
Slide 2: Investor Presentation Q1 & FY27
Nath Bio-Genes (I) Ltd. Investor Presentation Q1 & FY27 www.nathbiogenes.com
Slide 3: Disclaimer
Disclaimer Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual
Slide 4: Competitive Positioning In A Tough Sector
Competitive Positioning In A Tough Sector Focus Area Winning Strategies Product Selection • Focus on Cotton, Wheat, Maize & • Build a dream-product basket with Fodder Bajra superior and diversified products • Empower Stakeholders; Build long- • Build an Un-paralleled Supply Chain term, loyal, symbio
Slide 5: What Our Business Delivered In Last 9 Years
What Our Business Delivered In Last 9 Years Average Selling Price (Rs/kg) is Increasing Revenue Growth (INR Mn) 1,244 CAGR 12.5% 4,316 1,917 480 293 128 FY18 FY26 FY19 FY26 Field Crops Vegetables 4
Slide 6: Tailor Made Products
Tailor Made Products Understand key farmer requirements based on deep market research. Develop products to suit various agri climatic conditions xc Focus on disease and pest resistance which automatically results in higher yield Stringent multistage trials before commercial development 5
Slide 7: Focused on R&D
1 R&D Team of experienced scientists and experts Focused on R&D 2 Prioritize Disease and Pest resistance breeding 3 Large and Diverse collection of Germplasm Well Invested, DSIR recognized R&D Innovation 4 Centres Produce Genetically Pure and Premium Quality 5 Seeds Cold storage facilities, warehous
Slide 8: Focused on Shareholder Value Creation
Focused on Shareholder Value Creation Growing Business Product Excellence Differentiated Margin Expansion Customer Experience Strong Positions in Innovation and Expanding market Growing EBITDA important crops solution that drive reach through new margins through productivity and and innovative effic
Slide 9: Farming Community's Testimonials
Farming Community’s Testimonials 8
Slide 10: Testimonials: Cotton Nath Sanket
: es Testimonials : Cotton Nath Sanket [Remar alel debe Ged St aoa Pura z, foteral ardt eiean & Sg ord 2 83 cht andl dean & Hrevt aE Waeaed Jaa tal él fese site abit & ufd saa aeareltesar e1 >
Slide 11: Testimonials: Cotton Jumbo-303
ite é Testimonials : Cotton Jumbo-303 yy NATH SEDs” Mel HI Weal-303 Um aEecdtar Ure el oa cht aes et saras 3g ae sere Hel aie mural aft qoretare 21 aede Scaal Sa zl NBC-1103 BGII Cato rae wt Bogard Te
Slide 12: Testimonials: Cotton Rana-900
of Testimonials : Cotton Rana-900 SS : an 3 ; ; ; Mel HI visal-303 Ua aectdter ) ay : : HUT el oa Ht cee et sares 5 (elie : 3 2g a8 sep & el sie mural aft deretare 2 aegg Salaat Sar al © eTur- 900!
Slide 13: Testimonials: Bajra-NBH-07
ite Testimonials : Bajra-NBH-07 om mel I Cat ft VA-07 Gerel Ua & NBH-07 ‘NATH HYBRID BAURA SEEDS = aN
Slide 14: Testimonials: Hy. Paddy-Dhadak Gold
ite Testimonials : Hy. Paddy-Dhadak Gold Se élslds alot ascp Iles Uch Seadter ener vont é1 Sa] GIT site Aetale Geil el Hea safe a waeaed seea ect 1 AS) = TS Q
Slide 15: Testimonials: Paddy-Nath 20/20
Testimonials : Paddy-Nath 20/20 eet o2l 20/20 Uap SSA eter BI Saal Howat st cen sfdep atet 21 HAGE aon é at wares Prec aati BEAT ALAH Vas Tat site ula arest sifdles aret @ saa arege tartare fatesct é1 ) NATH-20/20 NATH PADDY SEEDS x a & NATH SEDs”
Slide 16: Testimonials: Hy. Maize-Domnator-401
of Testimonials : Hy. Maize-Domnator-401 SS Sistas Aaenl sifetetce-401 os septs orestt et & site fete aap ae Se alee ch ape zl Ug Ub deed Suet calarest wernt feoeat 2
Slide 17: Testimonials: Hy. Okra-Akira
ey NATH SEEDS” Testimonials : Hy. Okra-Akira omel elstes fatost stestet vas clerala feoeH S1 Wee Ee GT ares Ud dutetare tes é1 she aeaed oat ect 21 aaa & ud aeatefies & AKIRA 920 rere, ee
Slide 18: Testimonials: Hy. Tomato-Akhand
ite Testimonials : Hy. Tomato-Akhand ase NATH SEDs” omel gistats cletct sieds sre as aaa & far aad dgadta feseart 81 Wee cores dT Gs sieprfos JTlestcpte SIA thes al died S4u1 fact él
Slide 19: Testimonials: Hy. Chili-NCH-1055
ite Testimonials: Hy. Cili-NCH-1055 IS Sistas Aa sifetetce-401 ds areptes oresf ara € site fate aap afe SS silepe & ae zl Ue Um dead Sun ectaTest aera feoea 21 NCH-1055
Slide 20: Testimonials: Hy. Bittergourd-NBIGH-274
Testimonials : Hy. Bittergourd-NBIGH-274 ae Slafas Heer va ot sa off va-274 te afear wicale Heat el Bat HI ST srepten Ger é Sie eit & ute Geateltes e1 sat A Agar 21 ecco, afer *, s SS.
Slide 21: Performance Q1 & FY27
SL Perit OF Q1 & FY27 eet ie — PERFORMANCE
Slide 22: Key Business Highlights
Key Business Highlights Cotton, Bajra, and Jowar maintained stable volume and value Maize recorded 44% growth in volume and 59% growth in value Paddy registered 19% growth in volume and 34% growth in value, primarily driven by a higher contribution from premium-value products The PNS segment recorde
Slide 23: Key Financial Highlights
Key Financial Highlights – FY26 Q1FY27 Q1FY26 YoY Revenue ₹ 3,228 Mn ₹ 2,802 Mn ▲ 15% Gross Profit ₹ 1,629 Mn ₹ 1,438 Mn ▲ 13% EBITDA ₹ 351 Mn ₹ 299Mn ▲ 17% PBT after Adjustment of ₹ 334 Mn ₹ 299 Mn ▲ 12% Exceptional Items 22
Slide 24: Segmental Revenue Contribution
Segmental Revenue Contribution Q1FY27 Revenue Q1FY26 Revenue INR 3,228 Mn INR 2,802Mn Others Others, Cotton 30% 31% 34% Cotton, 40% Paddy Paddy, 35% 30% Cotton Paddy Others Cotton Paddy Others • Others include: Jowar, Bajra, Maize, Mustard, Wheat 23
Slide 25: Income Statement
Income Statement Particulars (INR Mn) Q1FY27 Q1FY26 %Change(YoY) FY26 FY25 %Change(YoY) Total Revenue 3,228 2,802 15% 4,316 3,623 19% Gross Profit 1,629 1,438 13% 2,403 2,289 5% Gross Margin (%) 50% 51% 56% 63% EBITDA 351 299 17% 525 523 0% EBITDA Margin (%) 11% 11% 12% 14% Depreciation 10 10 3% 39
Slide 26: Appendix
APPENDIX 25
Slide 27: Maintaining Profitability; Strong Balance Sheet
Maintaining Profitability; Strong Balance Sheet Net Debt (INR Mn) Net Worth (INR Mn) 6,893 6,487 6,133 6,107 5,576 5,734 888 5,420 5,076 4,692 679 659 672 576 478 510 3,033 363 328 207 235 1,071 1,213 -121 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Slide 28: Visionary Leadership; Attracting the Best Talent
Visionary Leadership; Attracting the Best Talent Leadership Team Mr. Nandkishor Kagliwal Dr. Capt. Devinder Khurana Mr. Amol Gupta Chairman Executive Vice President CFO Dr. V. N. Kulkarni Mr. K. Reddy Mr. Harish Pandey Mr. Satish Kagliwal Head – R & D Head – Supply Chain Business Lead Managing Direc
Slide 29: Historical Income Statement
Historical Income Statement Nath Bio-Genes’ P&L Statement Particulars (INR Mn) FY26 FY25 FY24 FY23 FY22 Total Revenue 4,316 3,623 3,326 3,013 2,783 Gross Profit 2,403 2,289 1,991 1,667 1,544 Gross Margin (%) 56% 63% 60% 55% 56% EBITDA 525 523 505 489 373 EBITDA Margin (%) 12% 14% 15% 16% 13% Depreci
Slide 30: Historical Balance Sheet
Historical Balance Sheet Assets (INR Mn) FY26 FY25 FY24 FY23 FY22 Liabilities (INR Mn) FY26 FY25 FY24 FY23 FY22 Fixed Assets 2,437 2,430 2,406 2,340 2,329 Share Capital 190 190 190 190 190 Other Intangible 56 72 88 104 120 Assets Financial Assets 268 61 61 51 51 Reserves & Surplus 6,704 6,297 5,917
Slide 31: Thank You
Thank You CIN_NBIL_L01110MH1993PLC072842 For further information, please get in touch with: Sheetal Khanduja sheetal@GoIndiaadvisors.com M:+91 97693 64166 Deepika Sharma deepika@GoIndiaadvisors.com M:+91 8451029510
Nath Bio-Genes (India) — Q1 FY27 Earnings Presentation on 6ix